Anglo American Platinum Ltd
OTC:ANGPY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Anglo American Platinum Ltd
OTC:ANGPY
|
ZA |
|
M
|
Moderna Inc
F:0QF
|
US |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
Caixabank SA
F:48CA
|
ES |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
BioNTech SE
NASDAQ:BNTX
|
DE |
|
BOK Financial Corp
F:BJR
|
US |
|
H
|
Henry Schein Inc
XHAM:HS2
|
US |
|
N
|
Nikon Corp
DUS:NKN
|
JP |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
H
|
Helmerich and Payne Inc
XBER:HPC
|
US |
|
Cambricon Technologies Corp Ltd
SSE:688256
|
CN |
|
M
|
MGIC Investment Corp
XMUN:MGC
|
US |
|
V
|
Varonis Systems Inc
F:VS2
|
US |
|
I
|
Isetan Mitsukoshi Holdings Ltd
DUS:4HP
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ANGPY's stock price target?
Not Available
ANGPY does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Anglo American Platinum Ltd?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 1 year is 13%.
What is the Operating Income forecast for Anglo American Platinum Ltd?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 1 year is 32%.
What is the Net Income forecast for Anglo American Platinum Ltd?
Projected CAGR
149%
Over the last 14 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 1 year is 149%.
